Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026)
Vycor Medical (VYCO) reported Cash from Investing Activities of $2140.0 for Q1 2026, up 233.25% quarter-over-quarter from -$1606.0 in Q4 2025.
Vycor Medical (VYCO) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Cash from Investing Activities data on file, last reported at $2140.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $2140.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $704.0 (changed N/A YoY), and the FY2025 annual result was -$4383.0, down 4.38% from the prior year.
- Cash from Investing Activities improved to $2140.0 in Q1 2026 per VYCO's latest filing, from -$1606.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $2140.0 in Q1 2026 and troughed at -$5904.0 in Q4 2023.
- A 5-year average of -$1148.5 and a median of $170.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 4291.67% in 2023, then jumped 129.86% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at $322.0 in 2022, then slumped by 1933.54% to -$5904.0 in 2023, then jumped by 102.88% to $170.0 in 2024, then sank by 1044.71% to -$1606.0 in 2025, then soared by 233.25% to $2140.0 in 2026.
- Business Quant data shows VYCO's Cash from Investing Activities at $2140.0 in Q1 2026, -$1606.0 in Q4 2025, and $170.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 2,140.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,140.00 |
| Mar 31, 2026 | 2,140.00 |
| Dec 31, 2025 | -1,606.00 |
| Dec 31, 2025 | -1,606.00 |
| Dec 31, 2024 | 170.00 |
| Dec 31, 2024 | 170.00 |
| Sep 30, 2024 | -5,031.00 |
| Sep 30, 2024 | -5,031.00 |
| Mar 31, 2024 | 662.00 |
| Mar 31, 2024 | 662.00 |
| Dec 31, 2023 | -5,904.00 |
| Dec 31, 2023 | -5,904.00 |
| Sep 30, 2023 | -4,024.00 |
| Sep 30, 2023 | -4,024.00 |
| Jun 30, 2023 | 254.00 |
| Jun 30, 2023 | 254.00 |
| Mar 31, 2023 | 288.00 |
| Mar 31, 2023 | 288.00 |
| Dec 31, 2022 | 322.00 |
| Dec 31, 2022 | 322.00 |